Effect of tyramine and guanethidine on dopamine-beta-hydroxylase activity and norepinephrine concentrations in vesicular fraction of the heart and plasma of rats.
D000818:Animals; D004299:Dopamine beta-Hydroxylase / Q000097:blood / Q000378:metabolism*; D005725:Ganglia, Autonomic / Q000201:enzymology / Q000378:metabolism; D006145:Guanethidine / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism* / Q000648:ultrastructure; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism*; D051381:Rats; D013572:Synaptic Vesicles / Q000201:enzymology / Q000378:metabolism*; D014439:Tyramine / Q000494:pharmacology*
D006584:Hexamethonium Compounds; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine; D014439:Tyramine; D006145:Guanethidine